HR 8079 Summary

• Recognizes the week of May 5-11, 2024, as "Tardive Dyskinesia Awareness Week" in Florida.

• Tardive dyskinesia (TD) is an involuntary movement disorder characterized by uncontrollable, abnormal, and repetitive movements of the face, torso, and extremities that can result from prolonged use of dopamine receptor blocking medications like antipsychotics and antiemetics.

• Approximately 600,000 people in the United States have TD, with nearly 70 percent remaining undiagnosed.

• The American Psychiatric Association recommends that people taking these medications be regularly monitored and screened for TD by a health care provider.

• The U.S. Food and Drug Administration has approved two treatments for TD, and raising public and medical community awareness may encourage those with symptoms to seek medical consultation.